DGDV has invested in Again Bio, a CCUS startup focused on producing chemicals from CO2, to support its plans for research, development, and new manufacturing capabilities aimed at enhancing CO2 reduction efforts.
Target Company Overview
Again Bio is a pioneering startup focused on Carbon Capture, Utilization, and Storage (CCUS) technology, specifically aimed at producing chemicals from CO2. The company is dedicated to addressing climate change by transforming carbon emissions into valuable products, thus contributing to environmental sustainability.
With plans to enhance its product portfolio and increase production capacity, Again Bio is committed to advancing research and development. The company also aims to accelerate CO2 reduction efforts through the establishment of new manufacturing facilities.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Japan
The CCUS industry in Japan has been gaining traction as the country plays a vital role in addressing climate change and achieving its carbon neutrali
Similar Deals
Kyoto University Innovation Capital Co., Ltd. → Esep Co., Ltd.
2021
DGDV
invested in
Again Bio
in 2025
in a Other VC deal